Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Around 36% of employers said they provide coverage of GLP-1s for both diabetes and weight loss, the same 속 2025 and up from 34% in 2024, the survey said.
출처: CNBC Top News · 원문 보기